No profile data available.
Septerna, Inc. (SEPN) is a healthcare company in the multiple medical service providers industry, based in South San Francisco, United States, with about 123 full-time employees.
It reported revenue of $45.95 million for fiscal year 2025, up 4174.5% from fiscal year 2024, and net income of -$48.88 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $26.75 million, up 22375.6% from a year before. Its market capitalization was $1.79 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.
Septerna reported $45.95 million in revenue for fiscal year 2025, up 4174.5% from $1.08 million in fiscal year 2024. In Q2 2026 revenue was $26.75 million.
$1.79 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multiple medical service providers) include SBC Medical Group Holdings Incorporated (SBC), Krtl Holding Group, Inc. (KRTL), Regenerative Medical Technology Group Inc. (RMTG), Evome Medical Technologies Inc. (LNDZF).